Join
Live feed
·
PRReleasevia Quantisnow
908 Devices Inc. logo
Repligen Corporation logo

Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MASS (908 Devices Inc.), RGEN (Repligen Corporation) and more on Quantisnow.

Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices | Quantisnow